Richard E. Maroun - Aug 27, 2021 Form 4 Insider Report for Aadi Bioscience, Inc. (AADI)

Role
Director
Signature
/s/ Neil Desai, as Attorney-in-Fact
Stock symbol
AADI
Transactions as of
Aug 27, 2021
Transactions value $
$0
Form type
4
Date filed
8/31/2021, 08:25 PM
Previous filing
Aug 31, 2021
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AADI Stock option (right to buy) Award $0 +17.5K $0.00 17.5K Aug 27, 2021 Common Stock 17.5K $26.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month). The grant date is August 27, 2021.